|
28 Companies |
|
32 Products |
|
32 Products |
|
35 Mechanisms of Action |
|
2 Trials |
|
564 News |
|
| 123456789101112» |
- | Phase classification: Nutrition and Coping Education for Symptom and Weight Management for Fibromyalgia (clinicaltrials.gov) - Jul 27, 2023
P=N/A, N=45, Completed, Sponsor: University of Utah
Phase classification: P2 --> P=N/A
- | NN1213 / Novo Nordisk
Trial completion: Radial Extracorporeal Shock Wave Treatment (rESWT) of Myofascial Pain Syndrome in Low Back Pain (clinicaltrials.gov) - Apr 30, 2019
P=N/A, N=46, Completed, Sponsor: University of Sao Paulo
Phase classification: P2 --> P=N/A Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: FIBROPATHIC: Osteopathic Medicine in Fibromyalgia Syndrome (clinicaltrials.gov) - Apr 16, 2019
P=N/A, N=101, Completed, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Effects of Physical Therapy in Pain and Posture of Fibromyalgia Patients (clinicaltrials.gov) - Mar 21, 2019
P=N/A, N=40, Completed, Sponsor: University of Sao Paulo General Hospital
Active, not recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Efficiency of Repetitive Transcranial Magnetic Stimulation (rTMS) Sessions After a Successful 3 Week-treatment in Fibromyalgia (clinicaltrials.gov) - Feb 12, 2019
P=N/A, N=78, Completed, Sponsor: Centre Hospitalier Esquirol
Recruiting --> Completed Recruiting --> Completed | Trial completion date: Feb 2017 --> Jul 2017 | Trial primary completion date: Aug 2016 --> Jul 2017
- ||| NN1213 / Novo Nordisk
Trial completion, Trial primary completion date: THERMALGI: Evaluation of Spa Therapy in the Treatment of Fibromyalgia (clinicaltrials.gov) - Jan 11, 2019
P=N/A, N=220, Completed, Sponsor: Association Francaise pour la Recherche Thermale
Recruiting --> Completed | Trial completion date: Feb 2017 --> Jul 2017 | Trial primary completion date: Aug 2016 --> Jul 2017 Active, not recruiting --> Completed | Trial primary completion date: Sep 2017 --> Mar 2018
- | Trial completion: Transcutaneous Electrical Nerve Stimulation (TENS) and Fibromyalgia (FM) (clinicaltrials.gov) - Jan 10, 2019
P=N/A, N=43, Completed, Sponsor: Dana Dailey
Active, not recruiting --> Completed | Trial primary completion date: Sep 2017 --> Mar 2018 Recruiting --> Completed
- | Trial completion, Trial completion date, Trial primary completion date: Impact of Inclusion of a Therapy Dog Visit as Part of the Fibromyalgia Treatment Program (clinicaltrials.gov) - Jan 2, 2019
P=N/A, N=229, Completed, Sponsor: Mayo Clinic
Recruiting --> Completed Recruiting --> Completed | Trial completion date: Jun 2020 --> Oct 2018 | Trial primary completion date: Dec 2019 --> Oct 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: INA-DMD: Evolution of Myofascial Pain, Post-dry Needling. Repair and Measuring With Elastography, of Myofascial Tissue. (clinicaltrials.gov) - Dec 14, 2018
P=N/A, N=77, Completed, Sponsor: Basque Country University
Recruiting --> Completed | Trial completion date: Jun 2020 --> Oct 2018 | Trial primary completion date: Dec 2019 --> Oct 2018 Recruiting --> Completed | Trial completion date: Dec 2018 --> Mar 2017 | Trial primary completion date: Sep 2018 --> Jan 2017
- | esreboxetine (AXS-14) / Axsome Therap, Pfizer
Enrollment change: Maintenance of Efficacy. (clinicaltrials.gov) - Nov 29, 2018
P3, N=0, Withdrawn, Sponsor: Pfizer
Recruiting --> Completed | Trial completion date: Dec 2018 --> Mar 2017 | Trial primary completion date: Sep 2018 --> Jan 2017 N=650 --> 0
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date: The Effects of CBT and tDCS on Fibromyalgia Patients (clinicaltrials.gov) - Nov 28, 2018
P=N/A, N=15, Completed, Sponsor: Medical University of South Carolina
N=650 --> 0 Recruiting --> Completed | N=72 --> 15 | Trial completion date: Dec 2016 --> Sep 2017
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Cross-sectional Study of Fibromyalgia (clinicaltrials.gov) - Nov 20, 2018
P=N/A, N=124, Completed, Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Recruiting --> Completed | N=72 --> 15 | Trial completion date: Dec 2016 --> Sep 2017 Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Mar 2018 | Trial primary completion date: Apr 2018 --> Mar 2016
- | NN1213 / Novo Nordisk
Trial initiation date: Effectiveness of Manual Therapy in Patients With Tinnitus and Temporomandibular Joint Disorder. (clinicaltrials.gov) - Oct 26, 2018
P=N/A, N=64, Completed, Sponsor: Universidad Complutense de Madrid
Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Mar 2018 | Trial primary completion date: Apr 2018 --> Mar 2016 Initiation date: Jan 2016 --> Jan 2017
- | NN1213 / Novo Nordisk
Trial primary completion date: Explain Pain in Fibromyalgia Patients (clinicaltrials.gov) - Oct 1, 2018
P=N/A, N=88, Completed, Sponsor: Cardenal Herrera University
Initiation date: Jan 2016 --> Jan 2017 Trial primary completion date: Nov 2015 --> Feb 2016
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date: Working Memory Training for Chronic Neuropathic and Fibromyalgia Pain (clinicaltrials.gov) - Sep 5, 2018
P=N/A, N=82, Completed, Sponsor: Oslo University Hospital
Trial primary completion date: Nov 2015 --> Feb 2016 Recruiting --> Completed | N=160 --> 82 | Trial completion date: Feb 2019 --> Sep 2018
- | propranolol / Generic mfg.
Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Propranolol for Treating Fibromyalgia Pain (clinicaltrials.gov) - Aug 23, 2018
P1, N=15, Terminated, Sponsor: University of Utah
Recruiting --> Completed | N=160 --> 82 | Trial completion date: Feb 2019 --> Sep 2018 N=30 --> 15 | Trial completion date: Jan 2018 --> Jul 2018 | Recruiting --> Terminated | Trial primary completion date: Jan 2018 --> Apr 2018; The funding ended.
- | Trial completion date: Efficacy and Safety of IGN-ES001 in Chronic Widespread Pain With or Without Fibromyalgia (clinicaltrials.gov) - Aug 7, 2018
P=N/A, N=230, Completed, Sponsor: IgNova GmbH
N=30 --> 15 | Trial completion date: Jan 2018 --> Jul 2018 | Recruiting --> Terminated | Trial primary completion date: Jan 2018 --> Apr 2018; The funding ended. Trial completion date: Jul 2018 --> Dec 2017
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Home-based Transcranial Direct Current Stimulation in Fibromyalgia Patients (clinicaltrials.gov) - Aug 3, 2018
P2, N=20, Completed, Sponsor: Wolnei Caumo
Trial completion date: Jul 2018 --> Dec 2017 Recruiting --> Completed | N=32 --> 20 | Trial completion date: Dec 2018 --> Jun 2018 | Trial primary completion date: Aug 2017 --> May 2018
- | Trial completion: Efficacy and Safety of IGN-ES001 in Chronic Widespread Pain With or Without Fibromyalgia (clinicaltrials.gov) - Aug 3, 2018
P=N/A, N=230, Completed, Sponsor: IgNova GmbH
Recruiting --> Completed | N=32 --> 20 | Trial completion date: Dec 2018 --> Jun 2018 | Trial primary completion date: Aug 2017 --> May 2018 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Biobehavioral Pain Management in TMD (clinicaltrials.gov) - Jul 19, 2018
P=N/A, N=300, Completed, Sponsor: Johns Hopkins University
Active, not recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Effectiveness of Manual Therapy in Patients With Tinnitus and Temporomandibular Joint Disorder. (clinicaltrials.gov) - Jul 16, 2018
P=N/A, N=64, Completed, Sponsor: Universidad Complutense de Madrid
Recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion date, Trial primary completion date: INA-DMD: Evolution of Myofascial Pain, Post-dry Needling. Repair and Measuring With Elastography, of Myofascial Tissue. (clinicaltrials.gov) - Jul 10, 2018
P=N/A, N=88, Recruiting, Sponsor: Basque Country University
Recruiting --> Completed Trial completion date: Jun 2018 --> Dec 2018 | Trial primary completion date: Dec 2017 --> Sep 2018
- | Trial completion: Neuromodulation and Its Therapeutic Potentiality in Different Populations (clinicaltrials.gov) - Jul 6, 2018
P=N/A, N=45, Completed, Sponsor: Universidade Federal do Rio Grande do Norte
Trial completion date: Jun 2018 --> Dec 2018 | Trial primary completion date: Dec 2017 --> Sep 2018 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: A Study of the Effect of Rhythmic Sensory Stimulation on Fibromyalgia (clinicaltrials.gov) - Jun 20, 2018
P=N/A, N=50, Completed, Sponsor: Mount Sinai Hospital, Canada
Active, not recruiting --> Completed Recruiting --> Completed
- | Trial completion, Phase classification: Treatment of Temporomandibular Dysfunction With Hypertonic Dextrose Injection (clinicaltrials.gov) - Jun 19, 2018
P=N/A, N=30, Completed, Sponsor: Frusso, Ricardo, M.D.
Recruiting --> Completed Enrolling by invitation --> Completed | Phase classification: P2/3 --> PN/A
- | NN1213 / Novo Nordisk
Trial completion date, Trial primary completion date: Radial Extracorporeal Shock Wave Treatment (rESWT) of Myofascial Pain Syndrome in Low Back Pain (clinicaltrials.gov) - Jun 14, 2018
P=N/A, N=46, Active, not recruiting, Sponsor: University of Sao Paulo
Enrolling by invitation --> Completed | Phase classification: P2/3 --> PN/A Trial completion date: Jan 2015 --> Dec 2018 | Trial primary completion date: Dec 2014 --> Mar 2018
- | NN1213 / Novo Nordisk
Trial completion: BEMER in the Treatment of Pain in Fibromyalgia. (clinicaltrials.gov) - Jun 13, 2018
P=N/A, N=110, Completed, Sponsor: Central Finland Hospital District
Trial completion date: Jan 2015 --> Dec 2018 | Trial primary completion date: Dec 2014 --> Mar 2018 Enrolling by invitation --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Phase classification, Enrollment change: Effectiveness of Vitamin B in Reducing Temporomandibular Joint Disorder Pain (clinicaltrials.gov) - May 4, 2018
P2, N=27, Completed, Sponsor: The University of Hong Kong
Enrolling by invitation --> Completed Recruiting --> Completed | Phase classification: PN/A --> P2 | N=40 --> 27
- | NN1213 / Novo Nordisk
Trial completion: Evaluation of the Efficacy and Neurological Effects of Dry Needling in the Treatment of Myofascial Pain Syndrome (clinicaltrials.gov) - May 3, 2018
P=N/A, N=40, Completed, Sponsor: University of Sao Paulo General Hospital
Recruiting --> Completed | Phase classification: PN/A --> P2 | N=40 --> 27 Active, not recruiting --> Completed
- | Trial completion: A Randomized Trial of Oral Iron Therapy in Fibromyalgia (clinicaltrials.gov) - Apr 20, 2018
P3, N=120, Completed, Sponsor: Sanjay Gandhi Postgraduate Institute of Medical Sciences
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Enrollment closed, Enrollment change, Trial completion date, Trial primary completion date: FIBROPATHIC: Osteopathic Medicine in Fibromyalgia Syndrome (clinicaltrials.gov) - Mar 19, 2018
P=N/A, N=101, Active, not recruiting, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=150 --> 101 | Trial completion date: Apr 2018 --> Aug 2018 | Trial primary completion date: Nov 2017 --> Aug 2018
- || Trial completion date, Trial primary completion date: Efficacy and Safety of IGN-ES001 in Chronic Widespread Pain With or Without Fibromyalgia (clinicaltrials.gov) - Mar 3, 2018
P=N/A, N=230, Active, not recruiting, Sponsor: IgNova GmbH
Recruiting --> Active, not recruiting | N=150 --> 101 | Trial completion date: Apr 2018 --> Aug 2018 | Trial primary completion date: Nov 2017 --> Aug 2018 Trial completion date: Mar 2018 --> Jun 2018 | Trial primary completion date: Jan 2018 --> Dec 2017
- | Enrollment closed, Trial primary completion date: Cross-sectional Study of Fibromyalgia (clinicaltrials.gov) - Feb 15, 2018
P=N/A, N=100, Active, not recruiting, Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Trial completion date: Mar 2018 --> Jun 2018 | Trial primary completion date: Jan 2018 --> Dec 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2017 --> Apr 2018
- | pregabalin / Generic mfg.
Trial completion, Trial primary completion date: Brain Response to Single Dose of Pregabalin in Fibromyalgia (clinicaltrials.gov) - Feb 8, 2018
P2/3, N=27, Completed, Sponsor: Hospital de Clinicas de Porto Alegre
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2017 --> Apr 2018 Active, not recruiting --> Completed | Trial primary completion date: Jan 2016 --> Jan 2017
- | Trial completion, Trial primary completion date: Acute Effects of Exercise in Women With Fibromyalgia (FM) (clinicaltrials.gov) - Feb 5, 2018
P=N/A, N=55, Completed, Sponsor: G
Active, not recruiting --> Completed | Trial primary completion date: Jan 2016 --> Jan 2017 Recruiting --> Completed | Trial primary completion date: Dec 2017 --> Nov 2012
- | Trial completion, Enrollment change, HEOR: Influence of Intraoral Photobiomodulation in Individuals With Temporomandibular Joint Dysfunction (clinicaltrials.gov) - Jan 26, 2018
P=N/A, N=30, Completed, Sponsor: University of Nove de Julho
Recruiting --> Completed | Trial primary completion date: Dec 2017 --> Nov 2012 Recruiting --> Completed | N=20 --> 30
- | Trial completion, Phase classification: Photobiomodulation In the Masseter and Temporal In Patients With Temporomandibular Joint Dysfunction (clinicaltrials.gov) - Jan 26, 2018
P=N/A, N=15, Completed, Sponsor: University of Nove de Julho
Recruiting --> Completed | N=20 --> 30 Not yet recruiting --> Completed | Phase classification: P1/2 --> PN/A
- | Trial completion: CAMMPS: Comprehensive vs. Assisted Management of Mood and Pain Symptoms (clinicaltrials.gov) - Jan 23, 2018
P=N/A, N=294, Completed, Sponsor: VA Office of Research and Development
Not yet recruiting --> Completed | Phase classification: P1/2 --> PN/A Active, not recruiting --> Completed
- | Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
Enrollment change, Trial withdrawal: Botox for Treatment of TMJ Disorder With Bruxism (clinicaltrials.gov) - Jan 23, 2018
P1, N=0, Withdrawn, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed N=32 --> 0 | Not yet recruiting --> Withdrawn
- | Trial completion, Trial primary completion date: Effects of Combined Treatment With tDCS and Cognitive Training in Patients With Fibromyalgia (clinicaltrials.gov) - Dec 26, 2017
P=N/A, N=40, Completed, Sponsor: Hospital de Clinicas de Porto Alegre
N=32 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Completed | Trial primary completion date: Dec 2017 --> Jul 2017
- | Enrollment change, Trial primary completion date: Cross-sectional Study of Fibromyalgia (clinicaltrials.gov) - Dec 19, 2017
P=N/A, N=100, Recruiting, Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Recruiting --> Completed | Trial primary completion date: Dec 2017 --> Jul 2017 N=500 --> 100 | Trial primary completion date: Mar 2018 --> Dec 2017 | N=500 --> 100 | Trial primary completion date: Mar 2018 --> Dec 2017 | N=500 --> 100 | Trial primary completion date: Mar 2018 --> Dec 2017
- | Trial completion: TMDPACT: Tailored Self-Management of Temporomandibular Disorders (TMD) Using Health Information Technology (clinicaltrials.gov) - Nov 30, 2017
P=N/A, N=81, Completed, Sponsor: HealthPartners Institute
N=500 --> 100 | Trial primary completion date: Mar 2018 --> Dec 2017 | N=500 --> 100 | Trial primary completion date: Mar 2018 --> Dec 2017 | N=500 --> 100 | Trial primary completion date: Mar 2018 --> Dec 2017 Recruiting --> Completed
- | Trial primary completion date: TMDPACT: Tailored Self-Management of Temporomandibular Disorders (TMD) Using Health Information Technology (clinicaltrials.gov) - Nov 27, 2017
P=N/A, N=80, Recruiting, Sponsor: HealthPartners Institute
Recruiting --> Completed Trial primary completion date: Mar 2018 --> Nov 2017
- | Trial termination: Temporomandibular Disorder (TMD) Pain in Response to Jaw Advancement in People With TMD and Obstructive Sleep Apnea (clinicaltrials.gov) - Nov 14, 2017
P=N/A, N=9, Terminated, Sponsor: University of North Carolina, Chapel Hill
Trial primary completion date: Mar 2018 --> Nov 2017 Completed --> Terminated; Funding depleted
- | Trial initiation date, Trial suspension, Trial primary completion date: FM-OSA: Effect of CPAP on Symptoms of Patients With Fibromyalgia and Obstructive Sleep Apnea (clinicaltrials.gov) - Nov 8, 2017
P=N/A, N=54, Suspended, Sponsor: Women's College Hospital
Completed --> Terminated; Funding depleted Initiation date: Mar 2016 --> Dec 2018 | Recruiting --> Suspended | Trial primary completion date: Jan 2018 --> Jun 2020
- || Enrollment closed: Efficacy and Safety of IGN-ES001 in Chronic Widespread Pain With or Without Fibromyalgia (clinicaltrials.gov) - Nov 8, 2017
P=N/A, N=230, Active, not recruiting, Sponsor: IgNova GmbH
Initiation date: Mar 2016 --> Dec 2018 | Recruiting --> Suspended | Trial primary completion date: Jan 2018 --> Jun 2020 Recruiting --> Active, not recruiting
- | Trial completion: Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Randomized Single Blinded Investigational Trial (clinicaltrials.gov) - Nov 7, 2017
P=N/A, N=28, Completed, Sponsor: State University of New York at Buffalo
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Trial primary completion date: Effectiveness of Manual Therapy in Patients With Tinnitus and Temporomandibular Joint Disorder. (clinicaltrials.gov) - Nov 6, 2017
P=N/A, N=64, Recruiting, Sponsor: Universidad Complutense de Madrid
Active, not recruiting --> Completed Trial primary completion date: Jun 2017 --> Jun 2018
- | Trial completion, HEOR: Clinical Outcomes After Dry Needling on Cervical Muscles, and Quality of Life, in Patients With Fibromyalgia Syndrome. (clinicaltrials.gov) - Oct 19, 2017
P=N/A, N=64, Completed, Sponsor: Universidad de Almeria
Trial primary completion date: Jun 2017 --> Jun 2018 Active, not recruiting --> Completed
- || Enrollment closed, Phase classification: THERMALGI: Evaluation of Spa Therapy in the Treatment of Fibromyalgia (clinicaltrials.gov) - Sep 25, 2017
P=N/A, N=220, Active, not recruiting, Sponsor: Association Francaise pour la Recherche Thermale
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Phase classification: P3 --> PN/A